NDC 11822-4530-02 - Sinus Pressure and Congestion Relief PE Maximum Strength

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
11822-4530
Requested NDC
11822-4530-02
Package NDCs from labels
11822-4530-4, 11822-4530-7, 11822-4530-2, 11822-4530-02
Manufacturer
Rite Aid Corporation | LNK International, Inc.
Effective date
2026-05-01
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Rite Aid 44-453Rite Aid Corporation | LNK International, Inc.2026-05-01HUMAN OTC DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11822-4530-2Sinus Pressure and Congestion Relief PEMaximum Strength3 in 1 CARTONTABLET, FILM COATED320
11822-4530-2Sinus Pressure and Congestion Relief PEMaximum Strength24 in 1 BLISTER PACKTABLET, FILM COATED2420
11822-4530-4Sinus Pressure and Congestion Relief PEMaximum Strength1 in 1 CARTONTABLET, FILM COATED120
11822-4530-4Sinus Pressure and Congestion Relief PEMaximum Strength18 in 1 BLISTER PACKTABLET, FILM COATED1820
11822-4530-7Sinus Pressure and Congestion Relief PEMaximum Strength18 in 1 BLISTER PACKTABLET, FILM COATED1820
11822-4530-7Sinus Pressure and Congestion Relief PEMaximum Strength2 in 1 CARTONTABLET, FILM COATED220

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11822-4530SINUS PRESSURE AND CONGESTION RELIEF PE MAXIMUM STRENGTH (PHENYLEPHRINE HCL) TABLET, FILM COATED [RITE AID CORPORATION]19Current NDC, Legacy NDC, 6 package rows20250512_fccea3c5-42af-4939-82bc-d9409b75f91f.zip

DailyMed Socrata Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 354 · 7,069 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Rompe Tos X AdultsACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCLOPMX LLC05abb2db-d22e-90b5-e063-6294a90ace3f2026-11-04WarningsExact identifier
application number: M012
unii: 04JA59TNSJ
Tenalif Multi Symptom ReliefACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCLOPMX LLC05cd94e7-1808-3bb3-e063-6294a90a41402026-11-04WarningsExact identifier
application number: M012
unii: 04JA59TNSJ
COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50TITANIUM DIOXIDE, ZINC OXIDECOOLA, LLCcb95c712-1680-4040-e053-2995a90af0042026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Diphenhydramine HCLDIPHENHYDRAMINE HCLPD-Rx Pharmaceuticals, Inc.c1873a4c-661f-4896-bcc0-f6d3a655de942026-11-04WarningsExact identifier
application number: M012
Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38TITANIUM DIOXIDEEai-jr 286, Inc303d5d5a-4c7a-1e23-e063-6294a90a0e582026-11-04WarningsExact identifier
unii: 15FIX9V2JP
tabcin NIGHTACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEOPMX LLC0b3ed2bb-88ed-699e-e063-6394a90ac0232026-11-04WarningsExact identifier
application number: M012
Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta BeigeTITANIUM DIOXIDEEAI-JR 286, Inc.b9ea12e8-6ed9-d805-e053-2a95a90aa1072026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Pearl White Face Stick SPF 50PADIMATE O, TITANIUM DIOXIDEEai-jr 286, Incb69a75e0-8724-35ae-e053-2a95a90a5f342026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra S Dorian Kona Gold Signature Face Stick SPF 38TITANIUM DIOXIDEEai-jr 286, Incb6c316c3-661b-6428-e053-2a95a90a1a6b2026-11-04WarningsExact identifier
unii: 15FIX9V2JP
RESFRIOL DACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCLOPMX LLC0e9c96b9-41ac-0faf-e063-6294a90a8ab52026-11-04WarningsExact identifier
application number: M012
unii: 04JA59TNSJ
Histiacil CoughDEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESINOPMX LLC7ca99ad2-5127-4a33-bfc6-7c2f596a2b252026-11-04WarningsExact identifier
application number: M012
DEXTROMETHORPHAN HBR, GUAIFENESINDEXTROMETHORPHAN HBR, GUAIFENESINOPMX LLC9a16e7f3-78aa-0b01-e053-2a95a90ab19c2026-11-04WarningsExact identifier
application number: M012
Ampigrin Ultra Forte NightACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEOPMX LLCe11e71c3-fe7c-77c7-e053-2995a90a34b22026-11-04WarningsExact identifier
application number: M012
NitecinACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEOPMX LLCdfb56532-6f72-1e4d-e053-2a95a90a1c052026-11-04WarningsExact identifier
application number: M012
Pentrexcilina Night TimeACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEOPMX LLCe11e5c17-28f2-7186-e053-2995a90a51f62026-11-04WarningsExact identifier
application number: M012
Viro Flu PM ReliefACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEOPMX LLCe1553da8-3a89-e258-e053-2a95a90a47252026-11-04WarningsExact identifier
application number: M012
ActivcinACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEOPMX LLC.e06a4d72-cc8d-fd9d-e053-2995a90a7a762026-11-04WarningsExact identifier
application number: M012
unii: 04JA59TNSJ
Sinus DecongestionPSEUDOEPHEDRINE HCLKroger Company73c3a9ac-43d6-4ecd-9add-36ca1c40ba9c2026-11-04WarningsExact identifier
application number: M012
Better LivingPHENYLEPHRINE HYDROCHLORIDEBETTER LIVING BRANDS LLCaea0db7f-e01a-4d8e-9c20-4a5ef4a905d12026-11-03WarningsExact identifier
application number: M012
unii: 04JA59TNSJ
Maximum Strength Severe Congestion and CoughDEXTROMETHORPHAN HBR, GUAIFENESIN, AND PHENYLEPHRINE HCLSAFEWAY013b94a1-26c7-4371-981a-d1b9d7fd1c982026-11-03WarningsExact identifier
application number: M012
unii: 04JA59TNSJ

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.